STAT3 inhibitors tested in clinical trials for solid tumors. | Download Scientific Diagram
STAT3 inhibitors currently in clinical development according to... | Download Table
Cancers | Free Full-Text | STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma | HTML
STAT3 Inhibitors in Clinical Trials | Download Table
STAT3 as an emerging molecular target in pancreatic cancer | GICTT
STAT3 Inhibitors in Clinical Trials | Download Table
STAT3 Inhibitors in Cancer: A Comprehensive Update
A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance
Targeting STAT3 in Cancer Immunotherapy | Molecular Cancer | Full Text
Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma | PLOS ONE
Cancers | Free Full-Text | Targeting STAT3 in Cancer with Nucleotide Therapeutics | HTML
Approaching non-canonical STAT3 signaling to redefine cancer therapeutic strategy
Targeting STAT3 in Cancer Immunotherapy | Molecular Cancer | Full Text
Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer | OTT
Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity | Cell Death & Disease
Novel activators and small-molecule inhibitors of STAT3 in cancer - ScienceDirect
Targeting STAT3 in Cancer Immunotherapy | Molecular Cancer | Full Text
Frontiers | STAT3 Contributes to Radioresistance in Cancer
Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer
Signal transducer and activator of transcription 3 (STAT3) inhibitors... | Download Table
STAT3 inhibitors tested in clinical trials for solid tumors. | Download Scientific Diagram
Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation | Journal of Medicinal Chemistry
Welcome to Scientific Archives | A Brief Update on STAT3 Signaling: Current Challenges and Future Directions in Cancer Treatment
